In this review, we summarize the evolutionary diversity and functional characteristics of LEAP-2 across species, analyze its therapeutic potential in treating obesity, diabetes, addiction, and other diseases, and explore its potential clinical applications and limitations. This evidence concerns the gene LEAP2 and obesity due to melanocortin 4 receptor deficiency.